Get started
Author

Gernot Fugger

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
2018 · Markus Dold, Lucie Bartova, et al. · The International Journal of Neuropsychopharmacology · 87
PDF
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)
2018 · Gernot Fugger, Markus Dold, et al. · European Neuropsychopharmacology · 71
Psychiatric patients' perception of physical restraint
2015 · G. Fugger, A. Gleiss, et al. · Acta Psychiatrica Scandinavica · 53
Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression
2019 · Thomas Vanicek, Georg S. Kranz, et al. · Brain stimulation · 49
Melancholic features in major depression – a European multicenter study
2021 · Markus Dold, Lucie Bartova, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 44
Seasonality in Major Depressive Disorder: Effect of Sex and Age
2021 · Matthäus Fellinger, Thomas Waldhör, et al. · Journal of Affective Disorders · 36
PDF
Comorbid hypertension in patients with major depressive disorder – Results from a European multicenter study
2019 · Gernot Fugger, Markus Dold, et al. · European Neuropsychopharmacology · 33
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression
2019 · Gernot Fugger, Markus Dold, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 31
Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression
2021 · Lucie Bartova, Gernot Fugger, et al. · Journal of Psychiatric Research · 29
PDF
Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials
2015 · Markus Dold, Gernot Fugger, et al. · Schizophrenia Research · 29
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
2022 · Gernot Fugger, Lucie Bartova, et al. · European Archives of Psychiatry and Clinical Neuroscience · 27
Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
2021 · Lucie Bartova, Markus Dold, et al. · Depression and Anxiety · 23
PDF
Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study
2020 · Markus Dold, Lucie Bartova, et al. · European Neuropsychopharmacology · 22
Repetitive enhancement of serum BDNF subsequent to continuation ECT
2019 · T. Vanicek, G. S. Kranz, et al. · Acta Psychiatrica Scandinavica · 22
PDF
Pattern of inpatient care for depression: an analysis of 232,289 admissions
2020 · Gernot Fugger, Thomas Waldhör, et al. · BMC Psychiatry · 17
PDF
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
2020 · Gernot Fugger, Markus Dold, et al. · The International Journal of Neuropsychopharmacology · 15
PDF
Age as a moderating factor of treatment resistance in depression
2023 · Alexander Kautzky, Lucie Bartova, et al. · European Psychiatry · 13
The clinical perspective on late-onset depression in European real-world treatment settings
2024 · Lucie Bartova, Gernot Fugger, et al. · European Neuropsychopharmacology · 10
Silexan for treatment of anxiety and depression in the context of COVID-19
2023 · Lucie Bartova, Markus Dold, et al. · European Neuropsychopharmacology · 10
PDF
Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study
2021 · Markus Dold, Lucie Bartova, et al. · Journal of Affective Disorders · 10
The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression
2021 · Lucie Bartova, Markus Dold, et al. · Journal of Affective Disorders · 8
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
2023 · Lucie Bartova, Gernot Fugger, et al. · Journal of Affective Disorders · 7
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
2021 · Lucie Bartova, Gernot Fugger, et al. · The International Journal of Neuropsychopharmacology · 7
PDF
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
2021 · Gernot Fugger, Lucie Bartova, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 6
PDF
A country report: impact of COVID-19 lockdowns on involuntary psychiatric treatment in Austria
2023 · Matthäus Fellinger, Thomas Waldhör, et al. · BJPsych Open · 5
PDF
Works count: 51
Citation count: 692
H-index: 15
I10-index: 20
Year
Topic
Type